{"filings":[{"id":93085,"accession_number":"0001477932-26-002848","cik":1477960,"company_name":"LataMed AI Corp.","ticker":"CCTC","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Latamed AI Corp. authorizes 5M shares of Series C Voting Preferred Stock (20 votes/share)","event_type":"other_material","confidence":"high","bullets":["Board designated Series C Voting Preferred Stock: 5,000,000 shares authorized, non-convertible, non-redeemable.","Each Series C share carries 20 votes, voting with common stock as a single class on all matters.","Liquidation preference senior to common stock; dividends at board's discretion, subject to senior securities.","Protective provisions require majority vote of Series C holders for actions that create senior stock, amend terms, or dissolve company.","Certificate of Designation filed with Nevada Secretary of State on May 6, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93084,"accession_number":"0001477932-26-002735","cik":1477960,"company_name":"LataMed AI Corp.","ticker":"CCTC","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Catalyst Crew Technologies Corp. changes name to LataMed AI Corp.","event_type":"other_material","confidence":"high","bullets":["Name change effective April 28, 2026 upon filing Certificate of Amendment with Nevada Secretary of State.","The sole change is the corporate name; all other Articles of Incorporation provisions remain unchanged.","Company is a Nevada corporation; address in Caracas, Venezuela."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93083,"accession_number":"0001477932-26-002171","cik":1477960,"company_name":"LataMed AI Corp.","ticker":"CCTC","form_type":"8-K","filed_at":"2026-04-13T23:59:59+00:00","items":["1.01","2.01","7.01","9.01"],"status":"ready","headline":"Catalyst Crew acquires AI healthcare IP and Venezuelan subsidiary from CEO in related-party transactions","event_type":"other_material","confidence":"high","bullets":["Acquired AI healthcare analytics IP (CardioAI, PulmoAI, NeuroAI) from CEO via APA dated Feb 17, 2026.","Acquired 100% of Inversiones Long 33, C.A. from CEO on March 23, 2026; now wholly-owned subsidiary.","IP formally assigned to subsidiary on April 7, 2026 as internal reorganization; no additional consideration.","Press releases issued March-April 2026 announcing CardioAI, PulmoAI, NeuroAI platforms and operating structure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93082,"accession_number":"0001477932-26-002061","cik":1477960,"company_name":"LataMed AI Corp.","ticker":"CCTC","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Catalyst Crew Technologies appoints Carlos Peña as CFO effective March 31, 2026","event_type":"leadership","confidence":"high","bullets":["Carlos Peña, 38, appointed CFO; over 10 years experience in accounting, financial management, and audit.","Since March 2024, Peña served as Supervisor of Administration and Finance for Aerovip, an aviation firm.","No formal employment agreement or finalized compensation with Peña as of report date.","No family relationships or arrangements with any director/officer; no related transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104416,"accession_number":"0001477932-26-001029","cik":1477960,"company_name":"LataMed AI Corp.","ticker":"CCTC","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["5.06","1.01","2.01","3.02","5.01","5.02","9.01"],"status":"ready","headline":"Catalyst Crew Technologies completes asset acquisition and change of control, exits shell company status","event_type":"m_and_a","confidence":"high","bullets":["Acquired AI healthcare analytics platform and medical services assets from Kevin Rodan Levy for 12,000,000 restricted shares.","Kevin Rodan Levy purchased 28,000,000 shares from Andrew Gaudet for $10,000, becoming majority owner with 71.1% ownership.","Former directors Andrew Gaudet, Waqas Nakhwa, Navneet B. Tayal, and Vineet Jawa resigned; Levy appointed sole director and CEO, CFO, Secretary, and Treasurer.","Company ceased to be a shell company following the asset acquisition and intends to operate as a digital health technology firm."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}